Scirocchi, F.; Strigari, L.; Di Filippo, A.; Napoletano, C.; Pace, A.; Rahimi, H.; Botticelli, A.; Rughetti, A.; Nuti, M.; Zizzari, I.G.
Soluble PD-L1 as a Prognostic Factor for Immunotherapy Treatment in Solid Tumors: Systematic Review and Meta-Analysis. Int. J. Mol. Sci. 2022, 23, 14496.
https://doi.org/10.3390/ijms232214496
AMA Style
Scirocchi F, Strigari L, Di Filippo A, Napoletano C, Pace A, Rahimi H, Botticelli A, Rughetti A, Nuti M, Zizzari IG.
Soluble PD-L1 as a Prognostic Factor for Immunotherapy Treatment in Solid Tumors: Systematic Review and Meta-Analysis. International Journal of Molecular Sciences. 2022; 23(22):14496.
https://doi.org/10.3390/ijms232214496
Chicago/Turabian Style
Scirocchi, Fabio, Lidia Strigari, Alessandra Di Filippo, Chiara Napoletano, Angelica Pace, Hassan Rahimi, Andrea Botticelli, Aurelia Rughetti, Marianna Nuti, and Ilaria Grazia Zizzari.
2022. "Soluble PD-L1 as a Prognostic Factor for Immunotherapy Treatment in Solid Tumors: Systematic Review and Meta-Analysis" International Journal of Molecular Sciences 23, no. 22: 14496.
https://doi.org/10.3390/ijms232214496
APA Style
Scirocchi, F., Strigari, L., Di Filippo, A., Napoletano, C., Pace, A., Rahimi, H., Botticelli, A., Rughetti, A., Nuti, M., & Zizzari, I. G.
(2022). Soluble PD-L1 as a Prognostic Factor for Immunotherapy Treatment in Solid Tumors: Systematic Review and Meta-Analysis. International Journal of Molecular Sciences, 23(22), 14496.
https://doi.org/10.3390/ijms232214496
